Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TracePoint vision grid will identify workers who came in contact with a sick coworker and alert operational staff.Mateon’s patented AI camera grid system is similar to Amazon’s technology but at a...
-
Pune, June 08, 2020 (GLOBE NEWSWIRE) -- The global electrophysiology devices market size is projected to reach USD 10.51 billion by 2026. According to a report published by Fortune Business...
-
BRUXELLES, Belgique, 08 juin 2020 (GLOBE NEWSWIRE) -- Dans le cadre de son engagement permanent à offrir à ses clients les jeux les plus populaires des meilleurs fournisseurs, betFIRST a introduit...
-
BRUSSEL, België, June 08, 2020 (GLOBE NEWSWIRE) -- Als deel van hun voortdurend engagement om hun klanten de meest populaire spellen van de beste providers te bieden, heeft betFIRST Betsoft...
-
BRUSSELS, Belgium, June 08, 2020 (GLOBE NEWSWIRE) -- As part of their ongoing commitment to bringing their customers the most popular games from the best providers, betFIRST has introduced Betsoft...
-
First healthy volunteer has been dosed in a Phase I study of JS016, the first SARS-CoV-2 neutralizing antibody to enter the clinical stage in ChinaJunshi and Lilly will co-develop JS016 globallyJS016...
-
TORRINGTON, Conn., June 07, 2020 (GLOBE NEWSWIRE) -- Dymax Corporation expands its range of MD® Medical Device Adhesives with the introduction of MD® 250-CTH, a new cationic epoxy. It's formulated...
-
--Data strongly support expanding development into mast cell driven diseases----Data presented in a late-breaking session at EAACI Annual Congress 2020-- HAMPTON, N.J., June 06, 2020 (GLOBE...
-
SAN RAMON, Calif., June 05, 2020 (GLOBE NEWSWIRE) -- Castro Valley Health, Inc. has become aware of a data security incident that may have involved some personal information of former patients....
-
The Company’s Proposed Pharmaceutical Grade Version of Tauri-Gum™ is Being Developed for Nausea Regulation, Intended Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment(s)...